The hemp-CBD industry is estimated to reach $22 billion by 2020 While still focusing on providing financial information and services, ChineseInvestors.com also aims to be a recognizable leader in the hemp-based CBD oil industry The company is considering a Nasdaq … Continue reading →

CIIX recently established a new website to present its domestic CBD line and offer consumers one-stop shopping convenience CIIX’s CBD Biotechnology Co. Ltd has a separate line designed for the Chinese market CIIX CEO says that additional opt brand industrial … Continue reading →

CEO Warren Wang discussed time with CIIX Spin-off of CBD, hemp products nearing completion CIIX went from nearly bankrupt to becoming publicly traded; Wang invested directly and looks forward to a promising future CEO Warren Wang of ChineseInvestors.com Inc. (OTCQB: … Continue reading →

Growth by acquisition will be a priority following IPO spin-off, according to CIIX CEO Warren Wang CIIX reported significant revenue growth, with hemp and CBD sales increasing by eight times year-over-year Industry trend may indicate more hemp or marijuana being … Continue reading →

Total revenue in the second quarter of fiscal year 2019 up to $648,265 Revenue growth is due to an increase in hemp and CBD product sales, as well as heightened subscriptions totals As the hemp and CBD markets continue to … Continue reading →

China has a centuries-old tradition of promoting herbs and other earthy, natural health remedies The village of Bama in China’s southern region has gained renown for the percentage of centenarians amid its population, and as the source of hemp rice … Continue reading →

CIIX recently hired Boustead Securities LLC as underwriter for the planned IPO of its wholly owned subsidiary, CBD Biotech Warren Wang, CEO of CIIX, said that the move is part of its strategic plan, as CIIX looks to return to … Continue reading →

Company has retained Boustead Securities for underwriting of the planned IPO for wholly owned foreign enterprise CBD Biotech CIIX is taking necessary steps to support the growth strategy currently in place for CBD Biotech With the finalized spinoff of CBD … Continue reading →

Alongside its traditional set of offerings for the Chinese-speaking investment community, ChineseInvestors.com is making strategic moves to capitalize on the burgeoning CBD oil industry Alex Hamilton has been appointed as chief financial officer of subsidiary company CBD Biotechnology, LTD ChineseInvestors.com … Continue reading →

Strategy is to expand its product line, leverage VitaMist’s branding and longevity, and utilize the company’s spray technology for a delivery system as a future for CBD consumption The LOI is with BCDBG, Inc., parent of VistaMist, for sales by … Continue reading →